Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HAE | Non-qualified Stock Option (Right to Buy) | Award | $0 | +32.1K | $0.00 | 32.1K | May 17, 2024 | Common Stock | 32.1K | $95.73 | Direct | F5 |
Id | Content |
---|---|
F1 | Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. |
F2 | This number includes unvested RSUs previously reported. |
F3 | The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. |
F4 | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. |
F5 | Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |